Urovant Sciences (NASDAQ: UROV) reported Q1 EPS of ($0.94), $0.14 better than the analyst estimate of ($1.08).Recent Business HighlightsAnnounced the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE